Single agent activity of PIK3CA inhibitor BYL719 in a broad cancer cell line panel

Category Primary study
JournalCancer Research
Year 2012
This article has no abstract
Epistemonikos ID: 7ec8b913a453e621d36ed8b78ea2350599a31c77
First added on: Feb 05, 2025